US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Ensysce Biosciences Inc.

0.5470

-0.0108-1.94%

Pre-market: 0.5326-0.0144-2.63%08:20 EDT

Volume:173.51K

Turnover:92.12K

Market Cap:1.99M

PE:-0.09

High:0.5474

Open:0.5400

Low:0.5163

Close:0.5578

52wk High:4.85

52wk Low:0.3144

Shares:3.63M

Float Shares:3.12M

Volume Ratio:0.32

T/O Rate:5.56%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-6.0968

EPS(LYR):-11.4482

ROE:-294.39%

ROA:-109.79%

PB:1.65

PE(LYR):-0.05

Loading ...

Overview Company News Filings

Ensysce Biosciences Inc expected to post a loss of $1.26 a share - Earnings Preview

Ensysce Biosciences Outlines Plans to Sequence PF614-301 Phase 3 Timeline, Reduce Regulatory Uncertainty, Prioritize PF614 and Related Pipeline Programs, and Evaluate PF614 Commercial Opportunities

Ensysce Biosciences announces publication on MPAR technology

Ensysce Biosciences reports Phase 1 clinical results for PF614-MPAR overdose-protection opioid technology

Nasdaq Flags Ensysce Biosciences for Sub-$1 Bid Price Noncompliance

AbbVie Inc Stock Closed Up by 3.12% on Feb 27: What Signal Does It Send?

Gilead Sciences Inc Stock Moved Up by 3.72% on Feb 27: What Investors Need To Know

Tiny Pain-Focused Biotech Ensysce Biosciences Surges Amid Strategic Review

Benzinga_recent_news

Top Premarket Gainers

MT Newswires Live

Ensysce Biosciences initiates review of strategic alternatives

Ensysce Biosciences Launches Strategic Alternatives Review to Pursue Partnerships, Licensing, and Other Transactions to Advance TAAP and MPAR Platforms

Ensysce Biosciences Executives to Present at USASP Annual Scientific Meeting

Ensysce Biosciences Reaches Key Enrollment Milestone in Phase 3 Trial of PF614 for Acute Pain

Ensysce Biosciences expands global opioid patent portfolio

Ensysce Biosciences Inc. held annual shareholder meeting

Ensysce Biosciences Launches Phase 3 Trial of Abuse-Resistant Opioid PF614

Ensysce Biosciences Secures New U.S. Patent for MPAR® Overdose Protection Technology, Extending Coverage Through 2042

Ensysce Biosciences Inc. Announces Date for Upcoming Annual Stockholders Meeting

Ensysce Biosciences receives FDA feedback on PF614 manufacturing

Ensysce Biosciences secures $4M financing

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ENSC/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ENSC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ENSC\",,,,,undefined,":{"symbol":"ENSC","market":"US","secType":"STK","nameCN":"Ensysce Biosciences Inc.","latestPrice":0.547,"timestamp":1774555200000,"preClose":0.5578,"halted":0,"volume":173511,"hourTrading":{"tag":"盘前","latestPrice":0.5326,"preClose":0.547,"latestTime":"08:20 EDT","volume":5931,"amount":3158.1483696,"timestamp":1774614015225,"change":-0.0144,"changeRate":-0.026325,"amplitude":0.016636},"delay":0,"changeRate":-0.01936177841520244,"floatShares":3119300,"shares":3632307,"eps":-6.0968,"marketStatus":"Pre-Mkt","change":-0.0108,"latestTime":"03-27 08:39:00 EDT","open":0.54,"high":0.547401,"low":0.5163,"amount":92119.3149474,"amplitude":0.055757,"askPrice":0.5934,"askSize":100,"bidPrice":0.4852,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-6.0968,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1774618200000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":0.547,"preHourTrading":{"tag":"盘前","latestPrice":0.5326,"preClose":0.547,"latestTime":"08:20 EDT","volume":5931,"amount":3158.1483696,"timestamp":1774614015225,"change":-0.0144,"changeRate":-0.026325,"amplitude":0.016636},"postHourTrading":{"tag":"盘后","latestPrice":0.538,"preClose":0.547,"latestTime":"19:55 EDT","volume":8016,"amount":4281.3407,"timestamp":1774569321853,"change":-0.009,"changeRate":-0.016453,"amplitude":0.031079},"volumeRatio":0.31772175199740993,"impliedVol":3.1521,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ENSC\",,,,,undefined,":{"symbol":"ENSC","floatShares":3119300,"roa":"-109.79%","roe":"-294.39%","lyrEps":-11.448165,"volumeRatio":0.31772175199740993,"shares":3632307,"dividePrice":0,"high":0.547401,"amplitude":0.055757,"preClose":0.5578,"low":0.5163,"week52Low":0.3144,"pbRate":"1.65","psRate":"0.44","week52High":4.85,"institutionHeld":0,"latestPrice":0.547,"eps":-6.0968,"divideRate":0,"volume":173511,"delay":0,"ttmEps":-6.0968,"open":0.54,"prevYearClose":0.92,"prevWeekClose":0.5841,"prevMonthClose":0.6232,"prevQuarterClose":0.92,"fiveDayClose":0.575,"twentyDayClose":0.395,"sixtyDayClose":1.01},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ENSC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-14","symbol":"ENSC","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-08-13","symbol":"ENSC","fiscalQuarterEnding":"2025/06","expectedEps":-1.02,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-0.79},{"market":"US","date":"2025-05-13","symbol":"ENSC","fiscalQuarterEnding":"2025/03","expectedEps":-3.02,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"post","actualEps":-1.39},{"market":"US","date":"2025-03-10","symbol":"ENSC","fiscalQuarterEnding":"2024/12","expectedEps":-2.74,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741579200000,"reportTimeType":"post","actualEps":-2.9},{"market":"US","date":"2024-12-06","symbol":"ENSC","defaultRemindTime":1733495400000,"type":"split","dateTimestamp":1733461200000,"forFactor":15,"toFactor":1,"ratio":15}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ENSC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ENSC\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ENSC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ENSC","date":"2026-03-25","current":-0.089719,"percent":0.866149,"low":-1151.871294,"twenty":-1.04806,"median":-0.420508,"eighty":-0.219988,"high":2051.953734,"avg":-8.589897,"sd":269.428826,"marketCap":2005033},"quantilePoints":[{"date":"2021-07-02","current":2051.953734,"twenty":2050.538593,"median":2050.538593,"eighty":2051.387678,"marketCap":353522901},{"date":"2021-07-09","current":1665.538105,"twenty":1670.376702,"median":2037.802329,"eighty":2050.538593,"marketCap":286948898},{"date":"2021-07-16","current":1373.799461,"twenty":1582.794518,"median":1666.827366,"eighty":2047.99134,"marketCap":236686414},{"date":"2021-07-23","current":986.303472,"twenty":1176.265418,"median":1592.804232,"eighty":1966.125264,"marketCap":169926280},{"date":"2021-07-30","current":796.099172,"twenty":905.447974,"median":1416.070215,"eighty":1677.156928,"marketCap":137156742},{"date":"2021-08-06","current":598.835663,"twenty":785.954194,"median":1130.038123,"eighty":1667.600922,"marketCap":103171001},{"date":"2021-08-13","current":462.160228,"twenty":607.289814,"median":986.310516,"eighty":1664.774414,"marketCap":79623737},{"date":"2021-08-20","current":-800.661067,"twenty":514.012352,"median":880.640679,"eighty":1647.936568,"marketCap":79073287},{"date":"2021-08-27","current":-761.364824,"twenty":-747.61113,"median":789.758561,"eighty":1590.301804,"marketCap":75192390},{"date":"2021-09-03","current":-825.221223,"twenty":-767.750462,"median":676.332041,"eighty":1555.901866,"marketCap":81498848},{"date":"2021-09-10","current":-859.605437,"twenty":-780.52174,"median":598.835663,"eighty":1458.340968,"marketCap":84894633},{"date":"2021-09-17","current":-724.524585,"twenty":-780.52174,"median":555.860395,"eighty":1373.799461,"marketCap":71554048},{"date":"2021-09-24","current":-1102.750982,"twenty":-800.661067,"median":488.931707,"eighty":1361.174599,"marketCap":108907687},{"date":"2021-10-01","current":-704.876458,"twenty":-815.397165,"median":-708.560485,"eighty":1130.038123,"marketCap":69613599},{"date":"2021-10-08","current":-582.075678,"twenty":-800.661067,"median":-611.547874,"eighty":1000.40781,"marketCap":57485794},{"date":"2021-10-15","current":-582.075678,"twenty":-788.380994,"median":-604.17982,"eighty":986.317559,"marketCap":57485794},{"date":"2021-10-22","current":-547.691464,"twenty":-781.01294,"median":-601.723805,"eighty":986.303472,"marketCap":54090009},{"date":"2021-10-29","current":-540.32342,"twenty":-780.52174,"median":-596.811776,"eighty":885.234099,"marketCap":53362341},{"date":"2021-11-05","current":-552.603493,"twenty":-778.556926,"median":-582.075678,"eighty":880.640679,"marketCap":54575121},{"date":"2021-11-12","current":-542.779435,"twenty":-776.100911,"median":-575.935642,"eighty":879.231656,"marketCap":53604897},{"date":"2021-11-19","current":-2.041392,"twenty":-776.100911,"median":-559.971547,"eighty":796.099172,"marketCap":38445141},{"date":"2021-11-26","current":-2.034952,"twenty":-774.1361,"median":-555.059508,"eighty":785.954194,"marketCap":38323863},{"date":"2021-12-03","current":-1.609931,"twenty":-769.715274,"median":-550.147479,"eighty":769.891308,"marketCap":30319512},{"date":"2021-12-10","current":-5.705594,"twenty":-764.803244,"median":-542.779435,"eighty":694.367562,"marketCap":107452350},{"date":"2021-12-17","current":-3.812316,"twenty":-763.820838,"median":-539.095413,"eighty":648.151541,"marketCap":71796604},{"date":"2021-12-23","current":-6.594276,"twenty":-762.34723,"median":-537.867406,"eighty":615.743964,"marketCap":124188721},{"date":"2021-12-31","current":-6.053339,"twenty":-758.417601,"median":-6.594276,"eighty":588.690681,"marketCap":114001365},{"date":"2022-01-07","current":-5.138899,"twenty":-754.979176,"median":-6.175695,"eighty":578.5457,"marketCap":96779882},{"date":"2022-01-14","current":-4.224458,"twenty":-753.99677,"median":-5.705594,"eighty":551.774222,"marketCap":79558399},{"date":"2022-01-21","current":-3.078187,"twenty":-753.99677,"median":-5.692715,"eighty":524.720941,"marketCap":57970907},{"date":"2022-01-28","current":-2.150867,"twenty":-750.067147,"median":-5.409367,"eighty":500.767517,"marketCap":40506868},{"date":"2022-02-04","current":-2.073591,"twenty":-736.313461,"median":-5.254814,"eighty":478.223115,"marketCap":39051531},{"date":"2022-02-11","current":-2.073591,"twenty":-719.612556,"median":-4.939267,"eighty":276.652164,"marketCap":39051531},{"date":"2022-02-18","current":-1.39742,"twenty":-709.29729,"median":-4.623721,"eighty":-1.482424,"marketCap":26317336},{"date":"2022-02-25","current":-1.40386,"twenty":-687.68435,"median":-4.456288,"eighty":-1.367797,"marketCap":26438614},{"date":"2022-03-04","current":-1.378101,"twenty":-617.442308,"median":-4.218019,"eighty":-1.378101,"marketCap":25953502},{"date":"2022-03-11","current":-1.416739,"twenty":-611.056671,"median":-4.17294,"eighty":-1.367797,"marketCap":26681170},{"date":"2022-03-18","current":-1.584172,"twenty":-608.600654,"median":-3.915351,"eighty":-1.367797,"marketCap":29834399},{"date":"2022-03-25","current":-1.455377,"twenty":-606.635834,"median":-3.72216,"eighty":-1.378101,"marketCap":27408838},{"date":"2022-04-01","current":-0.909052,"twenty":-605.653428,"median":-3.026669,"eighty":-1.367797,"marketCap":26438614},{"date":"2022-04-08","current":-0.942412,"twenty":-601.723805,"median":-2.640286,"eighty":-1.243923,"marketCap":27408838},{"date":"2022-04-14","current":-0.892372,"twenty":-601.723805,"median":-2.31186,"eighty":-1.109211,"marketCap":25953502},{"date":"2022-04-22","current":-0.884033,"twenty":-599.267791,"median":-2.221704,"eighty":-0.942412,"marketCap":25710946},{"date":"2022-04-29","current":-0.917392,"twenty":-599.267791,"median":-2.189506,"eighty":-0.917392,"marketCap":26681170},{"date":"2022-05-06","current":-0.935552,"twenty":-594.355761,"median":-2.131548,"eighty":-0.917392,"marketCap":27209326},{"date":"2022-05-13","current":-0.797005,"twenty":-582.075678,"median":-2.08647,"eighty":-0.892372,"marketCap":23214444},{"date":"2022-05-20","current":-0.624837,"twenty":-582.075678,"median":-2.073591,"eighty":-0.867353,"marketCap":18199682},{"date":"2022-05-27","current":-0.62899,"twenty":-582.075678,"median":-2.041392,"eighty":-0.82967,"marketCap":18320644},{"date":"2022-06-03","current":-0.645958,"twenty":-578.146055,"median":-2.034952,"eighty":-0.778733,"marketCap":18814863},{"date":"2022-06-10","current":-0.587461,"twenty":-575.198838,"median":-1.960895,"eighty":-0.698325,"marketCap":17111019},{"date":"2022-06-17","current":-0.537744,"twenty":-566.848388,"median":-1.931917,"eighty":-0.663661,"marketCap":15662924},{"date":"2022-06-24","current":-0.547118,"twenty":-561.936359,"median":-1.803122,"eighty":-0.641971,"marketCap":15935954},{"date":"2022-07-01","current":-0.675147,"twenty":-559.971547,"median":-1.758044,"eighty":-0.628942,"marketCap":19665057},{"date":"2022-07-08","current":-0.740288,"twenty":-558.006731,"median":-1.63569,"eighty":-0.63179,"marketCap":21562441},{"date":"2022-07-15","current":-0.73318,"twenty":-554.077102,"median":-1.584172,"eighty":-0.639978,"marketCap":21355409},{"date":"2022-07-22","current":-0.750097,"twenty":-552.603493,"median":-1.526215,"eighty":-0.650372,"marketCap":21848142},{"date":"2022-07-29","current":-0.645214,"twenty":-550.638681,"median":-1.455377,"eighty":-0.648267,"marketCap":18793198},{"date":"2022-08-05","current":-0.542837,"twenty":-547.691464,"median":-1.436058,"eighty":-0.628919,"marketCap":15811251},{"date":"2022-08-12","current":-0.502219,"twenty":-545.726652,"median":-1.416739,"eighty":-0.623627,"marketCap":18104172},{"date":"2022-08-19","current":-0.4432,"twenty":-541.797029,"median":-1.400842,"eighty":-0.597747,"marketCap":15976634},{"date":"2022-08-26","current":-0.437558,"twenty":-540.32342,"median":-1.39098,"eighty":-0.585573,"marketCap":15773232},{"date":"2022-09-02","current":-0.436493,"twenty":-539.341014,"median":-1.39098,"eighty":-0.574176,"marketCap":15734855},{"date":"2022-09-09","current":-0.364844,"twenty":-537.867406,"median":-1.38776,"eighty":-0.560252,"marketCap":13152036},{"date":"2022-09-16","current":-0.333012,"twenty":-537.867406,"median":-1.378101,"eighty":-0.543432,"marketCap":12004543},{"date":"2022-09-23","current":-0.234109,"twenty":-537.376203,"median":-1.352342,"eighty":-0.508327,"marketCap":8439255},{"date":"2022-09-30","current":-0.228893,"twenty":-429.647968,"median":-1.243734,"eighty":-0.498322,"marketCap":8251204},{"date":"2022-10-07","current":-0.234216,"twenty":-6.555638,"median":-1.18844,"eighty":-0.457146,"marketCap":8443092},{"date":"2022-10-14","current":-0.220376,"twenty":-6.367598,"median":-1.109211,"eighty":-0.440474,"marketCap":7944182},{"date":"2022-10-21","current":-0.210262,"twenty":-6.210469,"median":-1.003086,"eighty":-0.435641,"marketCap":7579594},{"date":"2022-10-28","current":-0.250893,"twenty":-6.104857,"median":-0.950752,"eighty":-0.392333,"marketCap":9044283},{"date":"2022-11-04","current":-0.17653,"twenty":-5.98379,"median":-0.934812,"eighty":-0.354113,"marketCap":6363632},{"date":"2022-11-11","current":-0.1248,"twenty":-5.705594,"median":-0.917392,"eighty":-0.266963,"marketCap":4498831},{"date":"2022-11-18","current":-0.202801,"twenty":-5.703018,"median":-0.904882,"eighty":-0.252442,"marketCap":5824224},{"date":"2022-11-25","current":-0.338332,"twenty":-5.692715,"median":-0.892372,"eighty":-0.252314,"marketCap":9716511},{"date":"2022-12-02","current":-0.220875,"twenty":-5.666956,"median":-0.884033,"eighty":-0.252314,"marketCap":6343293},{"date":"2022-12-09","current":-0.218547,"twenty":-5.525282,"median":-0.867353,"eighty":-0.245714,"marketCap":6276429},{"date":"2022-12-16","current":-0.173271,"twenty":-5.293452,"median":-0.82967,"eighty":-0.238048,"marketCap":4976162},{"date":"2022-12-23","current":-0.160808,"twenty":-5.254814,"median":-0.801912,"eighty":-0.234216,"marketCap":4618230},{"date":"2022-12-30","current":-0.167485,"twenty":-5.254814,"median":-0.794791,"eighty":-0.233587,"marketCap":4809988},{"date":"2023-01-06","current":-0.162144,"twenty":-5.208448,"median":-0.777262,"eighty":-0.229014,"marketCap":4656609},{"date":"2023-01-13","current":-0.172083,"twenty":-5.154354,"median":-0.761172,"eighty":-0.22176,"marketCap":4942034},{"date":"2023-01-20","current":-0.151312,"twenty":-4.979194,"median":-0.754483,"eighty":-0.220248,"marketCap":4345527},{"date":"2023-01-27","current":-0.15636,"twenty":-4.713877,"median":-0.749721,"eighty":-0.212142,"marketCap":4490485},{"date":"2023-02-03","current":-0.285115,"twenty":-4.654632,"median":-0.740288,"eighty":-0.212142,"marketCap":8188175},{"date":"2023-02-10","current":-0.319777,"twenty":-4.577355,"median":-0.716973,"eighty":-0.2146,"marketCap":9183632},{"date":"2023-02-17","current":-0.306121,"twenty":-4.487199,"median":-0.704416,"eighty":-0.217004,"marketCap":8791464},{"date":"2023-02-24","current":-0.268404,"twenty":-4.453712,"median":-0.69164,"eighty":-0.21887,"marketCap":7708271},{"date":"2023-03-03","current":-0.278653,"twenty":-4.399619,"median":-0.674554,"eighty":-0.220206,"marketCap":8002622},{"date":"2023-03-10","current":-0.295605,"twenty":-4.221882,"median":-0.670756,"eighty":-0.220476,"marketCap":8489450},{"date":"2023-03-17","current":-0.319044,"twenty":-4.206427,"median":-0.666784,"eighty":-0.220988,"marketCap":9162596},{"date":"2023-03-24","current":-0.28195,"twenty":-4.183244,"median":-0.656993,"eighty":-0.221547,"marketCap":8097283},{"date":"2023-03-31","current":-0.251749,"twenty":-4.160061,"median":-0.645586,"eighty":-0.223101,"marketCap":6085356},{"date":"2023-04-06","current":-0.180809,"twenty":-4.108543,"median":-0.632491,"eighty":-0.22144,"marketCap":4370577},{"date":"2023-04-14","current":-0.203676,"twenty":-3.992628,"median":-0.624837,"eighty":-0.218547,"marketCap":4923327},{"date":"2023-04-21","current":-0.218035,"twenty":-3.838075,"median":-0.616531,"eighty":-0.218035,"marketCap":5270402},{"date":"2023-04-28","current":-0.207399,"twenty":-3.812316,"median":-0.595341,"eighty":-0.211114,"marketCap":5013309},{"date":"2023-05-05","current":-0.186,"twenty":-3.72216,"median":-0.589774,"eighty":-0.207399,"marketCap":4496040},{"date":"2023-05-12","current":-0.170057,"twenty":-3.593365,"median":-0.578926,"eighty":-0.203676,"marketCap":4110665},{"date":"2023-05-19","current":-0.138524,"twenty":-3.078187,"median":-0.574237,"eighty":-0.198975,"marketCap":3519757},{"date":"2023-05-26","current":-0.119818,"twenty":-2.975152,"median":-0.564854,"eighty":-0.195168,"marketCap":3044461},{"date":"2023-06-02","current":-0.12184,"twenty":-2.799991,"median":-0.554475,"eighty":-0.191738,"marketCap":3095845},{"date":"2023-06-09","current":-0.11729,"twenty":-2.663469,"median":-0.544325,"eighty":-0.188162,"marketCap":2980232},{"date":"2023-06-16","current":-0.120324,"twenty":-2.403304,"median":-0.537744,"eighty":-0.185529,"marketCap":3057307},{"date":"2023-06-22","current":-0.110212,"twenty":-2.331179,"median":-0.512831,"eighty":-0.181667,"marketCap":2800390},{"date":"2023-06-30","current":-0.089484,"twenty":-2.31186,"median":-0.504284,"eighty":-0.180301,"marketCap":2273711},{"date":"2023-07-07","current":-0.108696,"twenty":-2.269358,"median":-0.500344,"eighty":-0.179074,"marketCap":2761853},{"date":"2023-07-14","current":-0.095551,"twenty":-2.235871,"median":-0.48602,"eighty":-0.176463,"marketCap":2427861},{"date":"2023-07-21","current":-0.228917,"twenty":-2.222992,"median":-0.463108,"eighty":-0.17453,"marketCap":5816563},{"date":"2023-07-28","current":-0.230007,"twenty":-2.204961,"median":-0.448416,"eighty":-0.176463,"marketCap":5844261},{"date":"2023-08-04","current":-0.212566,"twenty":-2.189506,"median":-0.439793,"eighty":-0.177048,"marketCap":5401094},{"date":"2023-08-11","current":-0.213656,"twenty":-2.17405,"median":-0.436546,"eighty":-0.178163,"marketCap":5428792},{"date":"2023-08-18","current":-0.284273,"twenty":-2.145715,"median":-0.431596,"eighty":-0.17894,"marketCap":5612832},{"date":"2023-08-25","current":-0.281373,"twenty":-2.132836,"median":-0.405938,"eighty":-0.179667,"marketCap":5555558},{"date":"2023-09-01","current":-0.268319,"twenty":-2.119956,"median":-0.373875,"eighty":-0.180213,"marketCap":5297826},{"date":"2023-09-08","current":-0.274121,"twenty":-2.107077,"median":-0.367186,"eighty":-0.180403,"marketCap":5412374},{"date":"2023-09-15","current":-0.255266,"twenty":-2.08647,"median":-0.356221,"eighty":-0.180828,"marketCap":5040094},{"date":"2023-09-22","current":-0.23061,"twenty":-2.083894,"median":-0.35054,"eighty":-0.181286,"marketCap":4553267},{"date":"2023-09-29","current":-0.197251,"twenty":-2.073591,"median":-0.336589,"eighty":-0.182977,"marketCap":3894618},{"date":"2023-10-06","current":-0.159541,"twenty":-2.068439,"median":-0.324381,"eighty":-0.181273,"marketCap":3150059},{"date":"2023-10-12","current":-0.175495,"twenty":-2.047832,"median":-0.319777,"eighty":-0.180154,"marketCap":3465064},{"date":"2023-10-20","current":-0.224808,"twenty":-2.041392,"median":-0.319097,"eighty":-0.180301,"marketCap":4438719},{"date":"2023-10-27","current":-0.15519,"twenty":-2.038816,"median":-0.31805,"eighty":-0.180213,"marketCap":3064148},{"date":"2023-11-03","current":-0.147166,"twenty":-2.034952,"median":-0.312913,"eighty":-0.177994,"marketCap":2905715},{"date":"2023-11-10","current":-0.135455,"twenty":-2.034952,"median":-0.311621,"eighty":-0.175524,"marketCap":2674479},{"date":"2023-11-17","current":-0.234708,"twenty":-2.022073,"median":-0.305807,"eighty":-0.175796,"marketCap":2957311},{"date":"2023-11-24","current":-0.219726,"twenty":-1.970555,"median":-0.300549,"eighty":-0.176418,"marketCap":2768546},{"date":"2023-12-01","current":-0.284645,"twenty":-1.951236,"median":-0.295186,"eighty":-0.17653,"marketCap":3586526},{"date":"2023-12-08","current":-0.245519,"twenty":-1.931917,"median":-0.292717,"eighty":-0.177824,"marketCap":3093536},{"date":"2023-12-15","current":-0.25718,"twenty":-1.931917,"median":-0.287495,"eighty":-0.178672,"marketCap":3240458},{"date":"2023-12-22","current":-0.26467,"twenty":-1.893278,"median":-0.287174,"eighty":-0.179342,"marketCap":3334840},{"date":"2023-12-29","current":-0.25718,"twenty":-1.839184,"median":-0.286889,"eighty":-0.179829,"marketCap":3240458},{"date":"2024-01-05","current":-0.287142,"twenty":-1.800546,"median":-0.286002,"eighty":-0.180183,"marketCap":3617987},{"date":"2024-01-12","current":-0.352061,"twenty":-1.787667,"median":-0.286889,"eighty":-0.180403,"marketCap":4435967},{"date":"2024-01-19","current":-0.29713,"twenty":-1.777363,"median":-0.287142,"eighty":-0.180809,"marketCap":3743830},{"date":"2024-01-26","current":-0.374533,"twenty":-1.738725,"median":-0.287142,"eighty":-0.180905,"marketCap":4719114},{"date":"2024-02-02","current":-0.36954,"twenty":-1.648569,"median":-0.287174,"eighty":-0.181297,"marketCap":4656192},{"date":"2024-02-09","current":-0.294633,"twenty":-1.62281,"median":-0.290994,"eighty":-0.182747,"marketCap":3712369},{"date":"2024-02-16","current":-0.476633,"twenty":-1.609931,"median":-0.289857,"eighty":-0.182811,"marketCap":6005566},{"date":"2024-02-23","current":-0.47931,"twenty":-1.589324,"median":-0.293303,"eighty":-0.183477,"marketCap":6039299},{"date":"2024-03-01","current":-0.49934,"twenty":-1.563565,"median":-0.295134,"eighty":-0.185529,"marketCap":6291674},{"date":"2024-03-08","current":-0.420937,"twenty":-1.537806,"median":-0.29713,"eighty":-0.187269,"marketCap":5303792},{"date":"2024-03-15","current":-0.401657,"twenty":-1.522351,"median":-0.301226,"eighty":-0.187592,"marketCap":5060871},{"date":"2024-03-22","current":-0.539343,"twenty":-1.509471,"median":-0.306121,"eighty":-0.187752,"marketCap":5724083},{"date":"2024-03-28","current":-0.552464,"twenty":-1.475984,"median":-0.311621,"eighty":-0.188069,"marketCap":5863337},{"date":"2024-04-05","current":-0.582158,"twenty":-1.455377,"median":-0.312913,"eighty":-0.188946,"marketCap":6178491},{"date":"2024-04-12","current":-0.520524,"twenty":-1.44765,"median":-0.317056,"eighty":-0.189992,"marketCap":5524363},{"date":"2024-04-19","current":-0.400674,"twenty":-1.43477,"median":-0.319149,"eighty":-0.190623,"marketCap":4252385},{"date":"2024-04-26","current":-0.390727,"twenty":-1.426836,"median":-0.324381,"eighty":-0.191499,"marketCap":4146813},{"date":"2024-05-03","current":-0.406665,"twenty":-1.420036,"median":-0.328965,"eighty":-0.192296,"marketCap":4315962},{"date":"2024-05-10","current":-0.38701,"twenty":-1.416739,"median":-0.333012,"eighty":-0.192744,"marketCap":4107370},{"date":"2024-05-17","current":-0.414034,"twenty":-1.409012,"median":-0.340203,"eighty":-0.194261,"marketCap":4778658},{"date":"2024-05-24","current":-0.386958,"twenty":-1.400239,"median":-0.345309,"eighty":-0.195168,"marketCap":4466149},{"date":"2024-05-31","current":-0.38446,"twenty":-1.397663,"median":-0.35054,"eighty":-0.195327,"marketCap":4437325},{"date":"2024-06-07","current":-0.35929,"twenty":-1.394844,"median":-0.352061,"eighty":-0.195908,"marketCap":4146813},{"date":"2024-06-14","current":-0.348315,"twenty":-1.39098,"median":-0.352127,"eighty":-0.196588,"marketCap":4020141},{"date":"2024-06-21","current":-0.358489,"twenty":-1.39098,"median":-0.352127,"eighty":-0.197251,"marketCap":4137567},{"date":"2024-06-28","current":-0.352192,"twenty":-1.39098,"median":-0.352192,"eighty":-0.197427,"marketCap":4064893},{"date":"2024-07-05","current":-0.295739,"twenty":-1.39098,"median":-0.352061,"eighty":-0.197948,"marketCap":3413327},{"date":"2024-07-12","current":-0.308291,"twenty":-1.39098,"median":-0.35054,"eighty":-0.199037,"marketCap":3558204},{"date":"2024-07-15","current":-0.302639,"twenty":-1.39098,"median":-0.349428,"eighty":-0.199099,"marketCap":3492971},{"date":"2024-08-02","current":-0.303954,"twenty":-1.39098,"median":-0.348315,"eighty":-0.199161,"marketCap":3508142},{"date":"2024-08-09","current":-0.241717,"twenty":-1.387116,"median":-0.345859,"eighty":-0.199565,"marketCap":2789826},{"date":"2024-08-16","current":-0.26447,"twenty":-1.380677,"median":-0.342074,"eighty":-0.199992,"marketCap":2982489},{"date":"2024-08-23","current":-0.307981,"twenty":-1.378101,"median":-0.336589,"eighty":-0.20065,"marketCap":3473180},{"date":"2024-08-30","current":-0.307305,"twenty":-1.370373,"median":-0.334845,"eighty":-0.202073,"marketCap":3465556},{"date":"2024-09-06","current":-0.364516,"twenty":-1.360069,"median":-0.341743,"eighty":-0.202979,"marketCap":4110738},{"date":"2024-09-13","current":-0.306193,"twenty":-1.352342,"median":-0.340037,"eighty":-0.203419,"marketCap":3453020},{"date":"2024-09-20","current":-0.321066,"twenty":-1.320968,"median":-0.335355,"eighty":-0.203676,"marketCap":3620738},{"date":"2024-09-27","current":-0.26527,"twenty":-1.261837,"median":-0.332941,"eighty":-0.20384,"marketCap":2991521},{"date":"2024-10-04","current":-0.225611,"twenty":-1.240811,"median":-0.332086,"eighty":-0.204208,"marketCap":2544273},{"date":"2024-10-11","current":-0.228772,"twenty":-1.222236,"median":-0.329966,"eighty":-0.204208,"marketCap":2579914},{"date":"2024-10-18","current":-0.220531,"twenty":-1.190942,"median":-0.325844,"eighty":-0.204432,"marketCap":2486982},{"date":"2024-10-25","current":-0.387436,"twenty":-1.154623,"median":-0.327156,"eighty":-0.205107,"marketCap":4369210},{"date":"2024-10-31","current":-0.78508,"twenty":-1.119973,"median":-0.329966,"eighty":-0.206243,"marketCap":8853546},{"date":"2024-11-08","current":-0.85568,"twenty":-1.097263,"median":-0.332086,"eighty":-0.207117,"marketCap":9649713},{"date":"2024-11-15","current":-1.112489,"twenty":-1.111833,"median":-0.332941,"eighty":-0.207179,"marketCap":8817483},{"date":"2024-11-22","current":-1.463005,"twenty":-1.187197,"median":-0.335355,"eighty":-0.2074,"marketCap":11595645},{"date":"2024-11-29","current":-1.219747,"twenty":-1.20095,"median":-0.339535,"eighty":-0.207404,"marketCap":9667605},{"date":"2024-12-06","current":-1.19258,"twenty":-1.236427,"median":-0.343222,"eighty":-0.208116,"marketCap":9452284},{"date":"2024-12-13","current":-1.007606,"twenty":-1.236427,"median":-0.346409,"eighty":-0.208205,"marketCap":7986196},{"date":"2024-12-20","current":-1.3089,"twenty":-1.236427,"median":-0.348396,"eighty":-0.208854,"marketCap":10374225},{"date":"2024-12-27","current":-1.541045,"twenty":-1.25409,"median":-0.351152,"eighty":-0.20886,"marketCap":12214182},{"date":"2025-01-03","current":-1.358293,"twenty":-1.336231,"median":-0.352061,"eighty":-0.209,"marketCap":10765705},{"date":"2025-01-10","current":-1.303961,"twenty":-1.349402,"median":-0.352192,"eighty":-0.209431,"marketCap":10335077},{"date":"2025-01-17","current":-1.152491,"twenty":-1.345121,"median":-0.352708,"eighty":-0.209959,"marketCap":9134538},{"date":"2025-01-24","current":-1.307254,"twenty":-1.346768,"median":-0.358489,"eighty":-0.210043,"marketCap":10361175},{"date":"2025-01-31","current":-1.104745,"twenty":-1.338865,"median":-0.359421,"eighty":-0.21027,"marketCap":8756107},{"date":"2025-02-07","current":-1.053706,"twenty":-1.330304,"median":-0.362904,"eighty":-0.210466,"marketCap":8351577},{"date":"2025-02-14","current":-0.996081,"twenty":-1.315486,"median":-0.36403,"eighty":-0.21134,"marketCap":7894850},{"date":"2025-02-21","current":-0.926932,"twenty":-1.3089,"median":-0.364942,"eighty":-0.212244,"marketCap":7346778},{"date":"2025-02-28","current":-0.864368,"twenty":-1.307254,"median":-0.367373,"eighty":-0.212536,"marketCap":6850903},{"date":"2025-03-07","current":-0.856136,"twenty":-1.303961,"median":-0.371707,"eighty":-0.212566,"marketCap":6785656},{"date":"2025-03-14","current":-0.637359,"twenty":-1.279265,"median":-0.374533,"eighty":-0.212566,"marketCap":5090547},{"date":"2025-03-21","current":-0.626307,"twenty":-1.273906,"median":-0.375127,"eighty":-0.213521,"marketCap":5002277},{"date":"2025-03-28","current":-0.548899,"twenty":-1.249136,"median":-0.377888,"eighty":-0.213656,"marketCap":4384018},{"date":"2025-04-04","current":-0.402877,"twenty":-1.247983,"median":-0.38361,"eighty":-0.213683,"marketCap":3217756},{"date":"2025-04-11","current":-0.330747,"twenty":-1.243734,"median":-0.377888,"eighty":-0.213752,"marketCap":2641651},{"date":"2025-04-17","current":-0.330747,"twenty":-1.241359,"median":-0.377888,"eighty":-0.214536,"marketCap":2641651},{"date":"2025-04-25","current":-0.582325,"twenty":-1.237295,"median":-0.37685,"eighty":-0.214732,"marketCap":4650993},{"date":"2025-05-02","current":-0.522509,"twenty":-1.233817,"median":-0.383262,"eighty":-0.215726,"marketCap":4173247},{"date":"2025-05-09","current":-0.365932,"twenty":-1.222431,"median":-0.382514,"eighty":-0.21608,"marketCap":2922678},{"date":"2025-05-16","current":-0.441183,"twenty":-1.219747,"median":-0.383262,"eighty":-0.217023,"marketCap":3006986},{"date":"2025-05-23","current":-0.447368,"twenty":-1.206773,"median":-0.38446,"eighty":-0.217878,"marketCap":3049140},{"date":"2025-05-30","current":-0.451491,"twenty":-1.201982,"median":-0.384903,"eighty":-0.218264,"marketCap":3077243},{"date":"2025-06-06","current":-0.564674,"twenty":-1.195928,"median":-0.386958,"eighty":-0.218495,"marketCap":3848663},{"date":"2025-06-13","current":-0.516411,"twenty":-1.19104,"median":-0.388248,"eighty":-0.21863,"marketCap":3519717},{"date":"2025-06-20","current":-0.513998,"twenty":-1.188835,"median":-0.39137,"eighty":-0.218686,"marketCap":3503270},{"date":"2025-06-27","current":-0.535716,"twenty":-1.185222,"median":-0.394081,"eighty":-0.219102,"marketCap":3651296},{"date":"2025-07-03","current":-0.557434,"twenty":-1.182061,"median":-0.399017,"eighty":-0.219726,"marketCap":3799321},{"date":"2025-07-11","current":-0.504345,"twenty":-1.180151,"median":-0.399987,"eighty":-0.219813,"marketCap":3437481},{"date":"2025-07-18","current":-0.751307,"twenty":-1.178504,"median":-0.401019,"eighty":-0.22017,"marketCap":5120707},{"date":"2025-07-25","current":-0.76522,"twenty":-1.176936,"median":-0.401964,"eighty":-0.220207,"marketCap":5215535},{"date":"2025-08-01","current":-0.726959,"twenty":-1.175387,"median":-0.402877,"eighty":-0.220276,"marketCap":4954758},{"date":"2025-08-08","current":-0.723481,"twenty":-1.169069,"median":-0.405593,"eighty":-0.220392,"marketCap":4931051},{"date":"2025-08-15","current":-0.929108,"twenty":-1.150186,"median":-0.408094,"eighty":-0.220472,"marketCap":6114994},{"date":"2025-08-22","current":-0.933618,"twenty":-1.139069,"median":-0.409736,"eighty":-0.220573,"marketCap":6144679},{"date":"2025-08-29","current":-0.947149,"twenty":-1.130745,"median":-0.414034,"eighty":-0.220768,"marketCap":6233732},{"date":"2025-09-05","current":-0.9697,"twenty":-1.127795,"median":-0.418503,"eighty":-0.220875,"marketCap":6382154},{"date":"2025-09-12","current":-0.960724,"twenty":-1.122663,"median":-0.421877,"eighty":-0.221392,"marketCap":6323082},{"date":"2025-09-19","current":-0.947149,"twenty":-1.117916,"median":-0.425864,"eighty":-0.22144,"marketCap":6233732},{"date":"2025-09-26","current":-1.019312,"twenty":-1.112489,"median":-0.430234,"eighty":-0.221723,"marketCap":6708683},{"date":"2025-10-03","current":-1.105007,"twenty":-1.11133,"median":-0.434538,"eighty":-0.221973,"marketCap":7272687},{"date":"2025-10-10","current":-1.050884,"twenty":-1.11133,"median":-0.435042,"eighty":-0.224695,"marketCap":6916474},{"date":"2025-10-17","current":-1.15913,"twenty":-1.114027,"median":-0.436493,"eighty":-0.224808,"marketCap":7628901},{"date":"2025-10-24","current":-0.951659,"twenty":-1.114027,"median":-0.438675,"eighty":-0.225611,"marketCap":6263416},{"date":"2025-10-31","current":-0.97421,"twenty":-1.112489,"median":-0.441183,"eighty":-0.225647,"marketCap":6411839},{"date":"2025-11-07","current":-0.933618,"twenty":-1.11133,"median":-0.4464,"eighty":-0.225968,"marketCap":6144679},{"date":"2025-11-14","current":-0.933618,"twenty":-1.109517,"median":-0.447368,"eighty":-0.226737,"marketCap":6144679},{"date":"2025-11-21","current":-0.519612,"twenty":-1.109211,"median":-0.450935,"eighty":-0.227075,"marketCap":5701431},{"date":"2025-11-28","current":-0.571251,"twenty":-1.10856,"median":-0.452846,"eighty":-0.227389,"marketCap":6268033},{"date":"2025-12-05","current":-0.526067,"twenty":-1.105685,"median":-0.460769,"eighty":-0.227585,"marketCap":5772257},{"date":"2025-12-12","current":-0.470074,"twenty":-1.104797,"median":-0.465167,"eighty":-0.227723,"marketCap":5157875},{"date":"2025-12-19","current":-0.377383,"twenty":-1.097738,"median":-0.463108,"eighty":-0.228568,"marketCap":4140829},{"date":"2025-12-26","current":-0.367452,"twenty":-1.095986,"median":-0.455656,"eighty":-0.228845,"marketCap":4031860},{"date":"2026-01-02","current":-0.304555,"twenty":-1.094182,"median":-0.452138,"eighty":-0.228893,"marketCap":3341722},{"date":"2026-01-09","current":-0.3509,"twenty":-1.089539,"median":-0.450036,"eighty":-0.228903,"marketCap":3850245},{"date":"2026-01-16","current":-0.297934,"twenty":-1.081354,"median":-0.447139,"eighty":-0.228917,"marketCap":3269076},{"date":"2026-01-23","current":-0.294194,"twenty":-1.072533,"median":-0.445907,"eighty":-0.228952,"marketCap":3228031},{"date":"2026-01-30","current":-0.238347,"twenty":-1.067528,"median":-0.440503,"eighty":-0.229277,"marketCap":2615261},{"date":"2026-02-06","current":-0.151946,"twenty":-1.060629,"median":-0.437558,"eighty":-0.228917,"marketCap":1667228},{"date":"2026-02-13","current":-0.136719,"twenty":-1.055386,"median":-0.43596,"eighty":-0.227954,"marketCap":1500142},{"date":"2026-02-20","current":-0.132581,"twenty":-1.055352,"median":-0.435042,"eighty":-0.227075,"marketCap":1454738},{"date":"2026-02-27","current":-0.13076,"twenty":-1.054591,"median":-0.434538,"eighty":-0.225611,"marketCap":1434761},{"date":"2026-03-06","current":-0.178396,"twenty":-1.053706,"median":-0.430234,"eighty":-0.221723,"marketCap":1957450},{"date":"2026-03-13","current":-0.143671,"twenty":-1.050884,"median":-0.425864,"eighty":-0.220741,"marketCap":1576421},{"date":"2026-03-20","current":-0.190347,"twenty":-1.049469,"median":-0.421877,"eighty":-0.220251,"marketCap":2088576},{"date":"2026-03-25","current":-0.182733,"twenty":-1.04806,"median":-0.420508,"eighty":-0.219988,"marketCap":2005033}],"updateTime":1774591712206},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ENSC\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2617630447","title":"Ensysce Biosciences Inc  expected to post a loss of $1.26 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2617630447","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617630447?lang=en_us&edition=fundamental","pubTime":"2026-03-07 04:55","pubTimestamp":1772830504,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences Inc  expected to post a loss of $1.26 a share - Earnings Preview Ensysce Biosciences Inc ENSC.OQ ENSC.O is expected to  show a fall in quarterly revenue when it reports  results on","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260306:nL8N3ZU2JK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENSC","BK4139"],"gpt_icon":0},{"id":"2616555619","title":"Ensysce Biosciences Outlines Plans to Sequence PF614-301 Phase 3 Timeline, Reduce Regulatory Uncertainty, Prioritize PF614 and Related Pipeline Programs, and Evaluate PF614 Commercial Opportunities","url":"https://stock-news.laohu8.com/highlight/detail?id=2616555619","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616555619?lang=en_us&edition=fundamental","pubTime":"2026-03-04 21:45","pubTimestamp":1772631919,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences Outlines Plans to Sequence PF614-301 Phase 3 Timeline, Reduce Regulatory Uncertainty, Prioritize PF614 and Related Pipeline Programs, and Evaluate PF614 Commercial Opportunities. Ensysce Biosciences said it plans to advance its PF614 program with a focus on Phase 3 execution and clearer timeline sequencing. The company also outlined efforts to reduce clinical and regulatory uncertainty, prioritize development across PF614, PF614-MPAR and its ADHD pipeline, and evaluate potential commercial opportunities for PF614. Ensysce said it will continue communications with stakeholders through its live AMA series and investor relations outreach.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260304:nNDL6h8BcD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENSC"],"gpt_icon":0},{"id":"2616234873","title":"Ensysce Biosciences announces publication on MPAR technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2616234873","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616234873?lang=en_us&edition=fundamental","pubTime":"2026-03-03 21:32","pubTimestamp":1772544768,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences (ENSC) announced the publication of the first clinical manuscript describing its MPAR overdose protection technology. The paper...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ensysce-biosciences-announces-publication-on-mpar-technology-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ensysce-biosciences-announces-publication-on-mpar-technology-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ENSC"],"gpt_icon":0},{"id":"2616340269","title":"Ensysce Biosciences reports Phase 1 clinical results for PF614-MPAR overdose-protection opioid technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2616340269","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616340269?lang=en_us&edition=fundamental","pubTime":"2026-03-03 21:00","pubTimestamp":1772542828,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences Inc. announced the first peer-reviewed clinical publication describing its MPAR  overdose protection technology, reporting Phase 1 results for PF614-MPAR, an oxycodone prodrug designed to limit additional opioid release when excessive numbers of pills are consumed. The Phase 1 data have already been presented in the published manuscript in the Journal of Opioid Management . The company also said a second clinical trial evaluating the MPAR technology is ongoing.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nNDLbxN1py:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENSC","BK4139"],"gpt_icon":0},{"id":"2614676378","title":"Nasdaq Flags Ensysce Biosciences for Sub-$1 Bid Price Noncompliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2614676378","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614676378?lang=en_us&edition=fundamental","pubTime":"2026-02-28 05:33","pubTimestamp":1772228022,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences Inc. received a Nasdaq deficiency notice saying it is out of compliance with Listing Rule 5550 after its stock closed below $1.00 for 30 consecutive business days. The company has until Aug. 24, 2026 to regain compliance by maintaining a closing bid price of at least $1.00 for at least 10 consecutive business days, or it could face potential delisting if it fails to cure the deficiency.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ensysce Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 27, 2026, and is solely responsible for the information ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260227:nNDL4L6p6z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENSC","BK4139"],"gpt_icon":0},{"id":"2614886727","title":"AbbVie Inc Stock Closed Up by 3.12% on Feb 27: What Signal Does It Send?","url":"https://stock-news.laohu8.com/highlight/detail?id=2614886727","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614886727?lang=en_us&edition=fundamental","pubTime":"2026-02-28 05:14","pubTimestamp":1772226857,"startTime":"0","endTime":"0","summary":"• FDA approved AbbVie's new CLL treatment regimen.\n• AbbVie will invest $380 million in new manufacturing facilities.\n• Analysts showed positive sentiment and upgraded AbbVie's rating.","market":"fut","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/stocks/261630822-market-movers-abbv-20260227","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","LU2237443895.HKD","ABBV","LU2089283258.USD","SG9999015986.USD","LU0234572021.USD","LU2087621335.USD","SG9999015978.USD","LU2112291526.USD","SG9999011175.SGD","LU2023251221.USD","LU1732799900.SGD","LU0170899867.USD","LU0820561818.USD","LU1989772840.SGD","LU1061106388.HKD","IE00BLSP4239.USD","SG9999015952.SGD","LU0795875086.SGD","LU1244550221.USD","LU0432979614.USD","LU1093756168.USD","LU1093756325.SGD","BK4550","LU0456855351.SGD","IE00B42XCP33.USD","IXHL","IE00BJT1NW94.SGD","LU2129689514.USD","LU1934455863.HKD","LU1989771016.USD","LU0114720955.EUR","SG9999015945.SGD","BK4559","LU0861579265.USD","IE0002270589.USD","LU1291159041.SGD","LU2089284900.SGD","LU0689472784.USD","LU0128525929.USD","ENSC","LU1496350502.SGD","LU2133065610.SGD","LU1074936037.SGD","LU1732800096.USD","EDSA","LU0289739343.SGD","LU1037948541.HKD","IE0002141913.USD","LU0820561909.HKD"],"gpt_icon":0},{"id":"2614869659","title":"Gilead Sciences Inc Stock Moved Up by 3.72% on Feb 27: What Investors Need To Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2614869659","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614869659?lang=en_us&edition=fundamental","pubTime":"2026-02-28 02:15","pubTimestamp":1772216124,"startTime":"0","endTime":"0","summary":"• Gilead Sciences is acquiring Arcellx, Inc. for $7.8 billion.\n• Gilead reported a 5% increase in Q4 product sales to $7.9 billion.\n• FDA approved expanded use for Gilead's Yescarta lymphoma treatment.","market":"us","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/stocks/261630467-market-movers-gild-20260227","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4550","LU2112291526.USD","LU2324357040.USD","LU0114720955.EUR","BK4007","LU0058720904.USD","LU0289739699.SGD","LU0122379950.USD","BK4583","BK4585","LU2087621335.USD","LU0234570918.USD","IE00B19Z3B42.SGD","IE00BSNM7G36.USD","SG9999015978.USD","ISBC","IE00B19Z3581.USD","LU1061106388.HKD","BK4578","BK4211","EDSA","SG9999015945.SGD","LU1057294990.SGD","BK4588","LU1839511570.USD","LU0861579265.USD","IXHL","IE00BKVL7J92.USD","BK4566","LU1066053197.SGD","BK4568","LU1585245621.USD","LU1037948897.HKD","IE0002270589.USD","GILD","IE00B3T34201.USD","IE00B7SZLL34.SGD","LU1023059063.AUD","LU1571399168.USD","LU0889565916.HKD","LU1066051498.USD","LU0109394709.USD","IE00BZ1G4Q59.USD","ENSC","LU0823416689.USD","LU1037948541.HKD","LU2468319806.SGD","BK4532","LU1430594728.SGD","LU0965509101.SGD"],"gpt_icon":0},{"id":"2614586543","title":"Tiny Pain-Focused Biotech Ensysce Biosciences Surges Amid Strategic Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2614586543","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614586543?lang=en_us&edition=fundamental","pubTime":"2026-02-28 01:10","pubTimestamp":1772212200,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences stock surged 58% after launching a strategic review to explore partnerships, licensing deals, or asset sales.","market":"hk","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/02/27/Loan-Section--Restructuring-And-Writing-.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/02/27/Loan-Section--Restructuring-And-Writing-.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/26/02/50936032/tiny-pain-focused-biotech-ensysce-biosciences-surges-amid-strategic-review","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/26/02/50936032/tiny-pain-focused-biotech-ensysce-biosciences-surges-amid-strategic-review","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4139","BK4585","ENSC","BK4588","LABU"],"gpt_icon":0},{"id":"2614071853","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2614071853","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614071853?lang=en_us&edition=fundamental","pubTime":"2026-02-27 20:41","pubTimestamp":1772196119,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences  shares were up 57% in Friday premarket activity, erasing Thursday's loss.Applied Optoelectronics  stock was up 19%, a day after the company posted a narrower Q4 non-GAAP net loss and higher revenue.Dell Technologies  stock was up 13% after the company reported overnight higher fiscal Q4 non-GAAP net income and revenue in addition to issuing higher-than-expected fiscal Q1 and 2027 outlook.Netflix  shares were 7.7% higher after the streaming company said Thursday it abandoned its plan to acquire Warner Bros. Discovery .","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0786609619.USD","IE00BKPKM429.USD","IE00B19Z9505.USD","LU2552382132.HKD","BK4588","LU0079474960.USD","LU1814569148.SGD","LU1035775433.USD","BK4587","LU0127658192.USD","LU1046421795.USD","LU1267930227.SGD","BK4170","LU1127390331.HKD","BK4598","LU1235294995.USD","LU0648001328.SGD","NFLW","BK4551","LU0211326755.USD","LU0109391861.USD","LU2361045086.USD","WBD","LU2361044949.HKD","SGXZ23171101.USD","BK4581","SGXZ51526630.SGD","LU2264538146.SGD","LU0225283273.USD","LU0006306889.USD","BK4535","LU1778281490.HKD","LU2237957902.USD","SG9999004303.SGD","BK4527","LU0320765059.SGD","LU0868494708.USD","LU1429558221.USD","LU2860962120.EUR","LU0980610538.SGD","LU2362541273.HKD","BK4585","LU1201861249.SGD","LU0353189763.USD","IE00B19Z8X17.USD","LU2108987350.USD","NFLU","LU1720051108.HKD","LU0708995401.HKD","LU1316542783.SGD","LU1232071149.USD","LU0052756011.USD","LU2237957811.SGD","LU0976567544.SGD","LU1988902786.USD","LU0210533765.USD","BK4507","LU2361044865.SGD","LU0130102774.USD","LU0128525689.USD","LU1064131342.USD","LU2552382215.SGD","LU2552382058.USD","BK4543","LU1720051017.SGD","LU0719512351.SGD","LU2543165471.USD","LU0082616367.USD","BK4534","BK4108","LU2087625088.SGD","LU2362540622.SGD","NFLY","LU0203201768.USD","LU2326559502.SGD","LU0267386448.USD","LU0256863811.USD","LU0106261372.USD","LU0310800965.SGD","LU0215105999.USD","LU0353189680.USD","BK4125","IE00BKVL7J92.USD","LU0868494617.USD","IE00B19Z4B17.USD","DELL","DLLL","IE00B19Z8W00.USD","LU0256863902.USD","IE00BQXX3D17.EUR","BK4566","LU0234570918.USD","LU0149725797.USD","LU2896262040.SGD","LU0942090050.USD","ENSC","LU1366192091.USD","LU1267930730.SGD","LU0211326839.USD","LU0882574139.USD","LU0477156953.USD","SGXZ99366536.SGD","BK4515","LU1674673428.USD","LU1823568750.SGD","LU0642271901.SGD","LU1435385759.SGD","BK4524","BK4548","LU2461242641.AUD","BK4139","SGXZ81514606.USD","BK4532","LU0672654240.SGD","BK4020","IE0031619046.USD","IE00BQXX3C00.GBP","LU2362541513.USD","NFLP","LU0097036916.USD","LU0077335932.USD","LU0234572021.USD","LU1069344957.HKD","LU1548497426.USD","LU1674673691.USD","IE00BZ1G4Q59.USD","LU0130517989.USD","LU0203202063.USD","LU2357305700.SGD","LU1989764664.SGD","NFXL","IE00BQXX3F31.USD","LU0417517546.SGD","LU0496365809.HKD","AAOI","NFXS","IE00B7SZL793.SGD","LU0210536198.USD","IE00B66KJ199.SGD"],"gpt_icon":1},{"id":"2614127087","title":"Ensysce Biosciences initiates review of strategic alternatives","url":"https://stock-news.laohu8.com/highlight/detail?id=2614127087","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614127087?lang=en_us&edition=fundamental","pubTime":"2026-02-25 21:17","pubTimestamp":1772025470,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences (ENSC) announced its Board of Directors has initiated a formal review of a broad range of strategic alternatives intended to en...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ensysce-biosciences-initiates-review-of-strategic-alternatives-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ensysce-biosciences-initiates-review-of-strategic-alternatives-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ENSC","BK4139"],"gpt_icon":0},{"id":"2614082197","title":"Ensysce Biosciences Launches Strategic Alternatives Review to Pursue Partnerships, Licensing, and Other Transactions to Advance TAAP and MPAR Platforms","url":"https://stock-news.laohu8.com/highlight/detail?id=2614082197","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614082197?lang=en_us&edition=fundamental","pubTime":"2026-02-25 21:00","pubTimestamp":1772024436,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences Launches Strategic Alternatives Review to Pursue Partnerships, Licensing, and Other Transactions to Advance TAAP and MPAR Platforms. Ensysce Biosciences said its board has launched a formal review of strategic alternatives aimed at enhancing shareholder value and supporting continued development of its TAAP and MPAR technology platforms. The company will evaluate options including strategic partnerships, licensing arrangements, capital formation transactions, business combinations, asset sales and other corporate transactions, and said it has not set a timetable for completing the review. Ensysce added it does not plan to provide further updates unless a specific transaction is approved or additional disclosure is required.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nNDLc96BCD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENSC","BK4139"],"gpt_icon":0},{"id":"2613278470","title":"Ensysce Biosciences Executives to Present at USASP Annual Scientific Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2613278470","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613278470?lang=en_us&edition=fundamental","pubTime":"2026-02-23 21:01","pubTimestamp":1771851690,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences Executives to Present at USASP Annual Scientific Meeting               Ensysce Biosciences (NASDAQ: ENSC) said its executives have been invited to participate in several upcoming s","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nNDL5hSQ6b:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","EVT.AU","SAVA","BK4007","BK4547","BK4139","BK7035","ENSC"],"gpt_icon":0},{"id":"2606190807","title":"Ensysce Biosciences Reaches Key Enrollment Milestone in Phase 3 Trial of PF614 for Acute Pain","url":"https://stock-news.laohu8.com/highlight/detail?id=2606190807","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606190807?lang=en_us&edition=fundamental","pubTime":"2026-01-28 21:02","pubTimestamp":1769605340,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences Inc. has announced that enrollment has reached 50% of the targeted subjects for interim review in its pivotal Phase 3 clinical trial of PF614, a next-generation opioid candidate for severe acute pain. The PF614-301 trial is a multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of PF614 for the treatment of moderate to severe pain following abdominoplasty. Enrollment began in late December 2025 and is ongoing at three U.S. clinical sites. Interim results from the study have not yet been presented and will be available in the future.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ensysce Biosciences Inc. published the original content used to generate this news brief via ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nNDL2Gcjpy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENSC","BK4139"],"gpt_icon":0},{"id":"2605107106","title":"Ensysce Biosciences expands global opioid patent portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2605107106","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605107106?lang=en_us&edition=fundamental","pubTime":"2026-01-21 21:15","pubTimestamp":1769001340,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences (ENSC) received a Notice of Allowance from the Brazilian Patent Office for the issuance of a patent covering additional opioid ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ensysce-biosciences-expands-global-opioid-patent-portfolio-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ensysce-biosciences-expands-global-opioid-patent-portfolio-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ENSC","BK4139"],"gpt_icon":0},{"id":"2602942315","title":"Ensysce Biosciences Inc. held annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2602942315","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602942315?lang=en_us&edition=fundamental","pubTime":"2026-01-09 06:15","pubTimestamp":1767910524,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences Inc. held its annual meeting of stockholders on January 7, 2026. Stockholders approved the issuance of shares of common stock and the exercise of warrants for common stock to an investor. An amendment to increase the number of shares available under the company's Omnibus Incentive Plan was also approved. The election of two Class I Directors, William Chang and Lee Rauch, was confirmed. Additionally, the appointment of Baker Tilly US, LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified. One proposal relating to the adjournment of the meeting was not submitted to a vote.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ensysce Biosciences Inc. published the","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nNDLb69ptZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENSC","BK4139"],"gpt_icon":0},{"id":"2590434980","title":"Ensysce Biosciences Launches Phase 3 Trial of Abuse-Resistant Opioid PF614","url":"https://stock-news.laohu8.com/highlight/detail?id=2590434980","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590434980?lang=en_us&edition=fundamental","pubTime":"2025-12-09 21:00","pubTimestamp":1765285259,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences Inc. has announced the initiation of enrollment in a pivotal Phase 3 clinical trial for PF614, its lead product candidate designed for pain management with built-in abuse protection. The company confirmed that the first patient has been enrolled in this trial. Results from the study have not yet been presented and will be available in the future.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ensysce Biosciences Inc. published the original content used to generate this news brief via ACCESS Newswire  on December 09, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nNDL6LXgWl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENSC"],"gpt_icon":0},{"id":"2588205343","title":"Ensysce Biosciences Secures New U.S. Patent for MPAR® Overdose Protection Technology, Extending Coverage Through 2042","url":"https://stock-news.laohu8.com/highlight/detail?id=2588205343","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588205343?lang=en_us&edition=fundamental","pubTime":"2025-12-02 21:01","pubTimestamp":1764680481,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences Inc. announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for a new patent covering its MPAR  technology. The patent, titled \"Compositions Comprising Enzyme-Cleavable Prodrugs and Controlled Release Nafamostat and Methods of Use Thereof,\" includes composition-of-matter and method-of-use claims, extending protection for MPAR through 2042. The technology is designed to provide overdose protection, with clinical trials demonstrating its ability to moderate opioid release when taken in excess.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ensysce Biosciences Inc. published the original content used to generate this news brief via ACCESS Newswire  on December 02, 2025, and is solely respo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nNDL38rTCN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENSC","BK4139"],"gpt_icon":0},{"id":"2585312388","title":"Ensysce Biosciences Inc. Announces Date for Upcoming Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2585312388","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585312388?lang=en_us&edition=fundamental","pubTime":"2025-11-22 03:22","pubTimestamp":1763752960,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences Inc. has announced that it will hold its Annual Meeting of Stockholders virtually on December 23, 2025. The meeting will address several proposals as outlined in the proxy statement provided to shareholders.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ensysce Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 21, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251121:nNDL5hLTpR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENSC"],"gpt_icon":0},{"id":"2584132566","title":"Ensysce Biosciences receives FDA feedback on PF614 manufacturing","url":"https://stock-news.laohu8.com/highlight/detail?id=2584132566","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584132566?lang=en_us&edition=fundamental","pubTime":"2025-11-20 21:36","pubTimestamp":1763645782,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences (ENSC) announced that the Food and Drug Administration provided Written Responses to a meeting request. Ensysce had requested g...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ensysce-biosciences-receives-fda-feedback-on-pf614-manufacturing-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ensysce-biosciences-receives-fda-feedback-on-pf614-manufacturing-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ENSC","BK4139"],"gpt_icon":0},{"id":"2584626269","title":"Ensysce Biosciences secures $4M financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2584626269","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584626269?lang=en_us&edition=fundamental","pubTime":"2025-11-17 21:30","pubTimestamp":1763386226,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences (ENSC) announced the closing of a $4 million convertible preferred stock financing, with upside to potentially $16 million of a...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ensysce-biosciences-secures-4m-financing-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ensysce-biosciences-secures-4m-financing-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ENSC","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":23,"code":"91000000","status":"200"}]}}